Variable | Univariate analysis | Multivariate analyisis | ||
---|---|---|---|---|
 | Hazard ratio (95% CI) | p-Value | Hazard ratio (95% CI) | p-Value |
Age (per year) | 1.125 (1.043–1.215) | 0.002 | 1.084 (0.935–1.256) | 0.286 |
STS score (per %) | 1.238 (1.037–1.477) | 0.018 | 1.365 (0.943–1.976) | 0.099 |
eGFR (per ml/min/1.73 m2) | 0.963 (0.936–0.991) | 0.010 | 0.988 (0.947–1.053) | 0.953 |
Baseline Mid LV CS (per %) | 1.016 (1.007–1.024) | 0.001 | 1.029 (1.007–1.052) | 0.009 |
Baseline LVEF (per %) | 0.962 (0.926–0.999) | 0.046 | 1.031 (0.949–1.119) | 0.473 |
TAVI procedure | 3.776 (1.283–11.109) | 0.016 | 0.397 (0.043–3.646) | 0.414 |
Myocardial Fibrosis (LGE + ve) | 1.670 (0.615–4.541) | 0.315 | - | - |
Baseline LVMI | 1.014 (0.993–1.035) | 0.189 | - | - |
History of MI | 0.611 (0.148–2.516) | 0.495 | - | - |
Mean Aortic PG | 1.018 (0.91–1.046) | 0.182 | - | - |
Indexed LA volume | 1.012 (0.982–1.043) | 0.428 | - | - |
LV mass:volume ratio | 8.051 (0.332–195.380) | 0.200 | - | - |
Zva | 1.788 (0.847–3.778) | 0.128 | - | - |
BMI | 1.211 (0.990–1.482) | 0.062 | - | - |
Diabetes Mellitus | 1.119 (0.162–7.744) | 0.909 | - | - |
Hyperlipidaemia | 1.795 (0.396–8.138) | 0.448 | - | - |
Hypertension | 0.578 (0.112–2.994) | 0.514 | - | - |
Previous MI | 0.960 (0.136–6.778) | 0.967 | - | - |
Previous PCI | 0.733 (0.101–5.305) | 0.758 | - | - |
Previous CABG | 0.243 (0.043–1.385) | 0.111 | - | - |
Atrial Fibrillation | 0.980 (0.144–6.673) | 0.984 | - | - |
Stroke/TIA | 0.742 (0.069–7.960) | 0.805 | - | - |
Peripheral Vascular Disease | 1.589 (0.145–17.400) | 0.705 | - | - |
COPD | 0.907 (0.125–6.586) | 0.924 | - | - |
Pulmonary Hypertension | 0.692 (0.112–4.267) | 0.692 | - | - |